PedAM
Pediatric Disease Annotations & Medicines
| Disease | myelodysplastic syndrome |
| Phenotype | C0040053|thrombosis |
| Sentences | 2 |
| PubMedID- 22102702 | Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes. |
| PubMedID- 19836075 | Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux. |
Page: 1